Evidence map›Paper›PMID 31900105›Full record

ArticleBMC infectious diseases2020

Mycoplasma penetrans bacteremia in an immunocompromised patient detected by metagenomic sequencing: a case report.

Benjamin Preiswerk, Frank Imkamp, Denise Vorburger, Rico V Hömke, Peter M Keller, Karoline Wagner

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Screening the receptors forFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
  5. Article
  6. Fluorescent optotracers for bacterial and biofilm detection and diagnostics.Science and technology of advanced materials · 2023
    Review
  7. Occurrence of urogenital mycoplasmas in men with the common genitourinary diseases.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  8. Article
  9. [Clinical implications of the genus Mycoplasma].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Benjamin PreiswerkInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Frank ImkampInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Denise VorburgerDepartment of Gynecology, University Hospital Zurich, Zurich, Switzerland.
Rico V HömkeInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Peter M KellerInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Karoline WagnerInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland. karoline.wagner@usb.ch.
University of Zurich · CHUniversity Hospital of Zurich · CH

Funding

Universität Zürich NA
6 · The paper itself

Abstract

backgroundMycoplasma sp. are well recognized as etiological agents of respiratory and sexually transmitted disease. Mycoplasma penetrans, a species of Mycoplasma sp., has been frequently detected in HIV-positive patients and associated with the progression of HIV-associated disease. To date, there is only a single case report describing M. penetrans as the causative agent of a severe respiratory tract infection in a HIV-negative patient. CASE PRESENTATION: In this report, we describe the case of M. penetrans bacteremia in a HIV-negative, 38-year-old, female, immunocompromised, solid organ transplant patient (combined kidney and pancreas transplantation in 2016), who was admitted to our hospital with anemic uterine bleeding and fever of 38.3 °C. Several hours before her admission at our university hospital, a latex bladder catheter was inserted into her uterus and she complained about fatigue, dizziness and ongoing vaginal bleeding. Laboratory examination showed severe anemia, but microbiological examination was inconspicuous (culture negative vaginal and cervical smears, negative urine culture). Bacterial blood cultures showed a growth signal after 4 h, but microscopic examination with Gram staining and subcultures on different agar media did not identify bacterial pathogens. To identify the bacterial cause of malignancy in the patient, metagenomic sequencing of the blood culture was performed that identified M. penetrans.

conclusionMetagenomic sequencing identified M. penetrans in an immunosuppressed patient with culture-negative bacteremia. Clinicians should be aware of the opportunistic potential of M. penetrans that may cause severe infections in certain vulnerable patient populations and the limitations of culture and Gram staining for confirming the presence of fastidious bacterial pathogens like Mycoplasma spp.

Indexed as

Immunocompromised HostMetagenomicsMycoplasma penetransAdultBacteremiaDiabetes Mellitus, Type 1DNA Mutational AnalysisFemaleHIV SeronegativityHumansKidney TransplantationMetagenomeMycoplasma InfectionsPancreas TransplantationRespiratory Tract InfectionsSequence Analysis, DNABacteremiaImmune deficiencyMetagenomic sequencingMycoplasma penetrans

Identifiers

PMID31900105
PMCPMC6942334
OpenAlexW2998607366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.